Join Management Sciences for Health (MSH) at the 47th Union World Conference on Lung Health (#unionconf) in Liverpool, UK from October 26-29, 2016.
MSH staff are preparing for our largest ever presence at The Union Comference; 50 posters and 13 oral presentations, plus speaking at 7 symposiums and 2 workshops, all highlighting the important and vital global work surrounding tuberculosis (TB) and lung health. In over 30 countries, MSH is working with international, national and local partners to strengthen the capacity of health systems, national TB programs, and health managers to improve the lives of those affected by TB and prevent the spread of disease.
We also will have a booth (#34) in the technical exhibition area. (See event highlights below.)
Highlights: MSH at #unionconf
A First Look and Clips from
“The Lucky Specials”
A Movie Demystifying TB
Hosted by Management Sciences for Health
Friday, October 28 | 5:30 – 7:00 p.m.
ACC Liverpool | Session Room 1A
How do you connect with the public about tuberculosis in a new way? How do you tell a compelling public health story in a world cluttered with health messages? The Leadership Management and Governance (LMG) Project implemented by MSH together with Discovery Learning Alliance (DLA), Howard Hughes Medical Institute (HHMI), and Wellcome Trust share their innovative initiative “The Lucky Specials,” a feature film aimed at changing how communities and individuals understand and respond to TB.
• Ambassador Deborah L. Birx
• Catharine Taylor, Vice President, Health Programs Group, MSH
• Tim Greene, co-writer, Producer, Quizzical Pictures
• Aric Noboa, Producer, President, Discovery Learning Alliance
• Laura Helft PhD, Senior Science Researcher, HHMI
• Wellcome Trust
• Allison Russel MBBCh, Treatment Advisor, USAID RHAP
Wednesday, October 26
11:15-14:15 | Session Room 7, ACC Liverpool
Workshop: Lessons learned from increasing access to Bedaquiline and Delamanid for management of drug resistance TB
The purpose of this session will be to present and share preliminary lessons learned from selected countries that have accessed Bedaquiline and Delamanid through the GDF. This information is relevant as countries plan to introduce Bedaquiline and Delamanid.
Thursday, October 27
10:30-12:00 | Session Room 8, ACC Liverpool
Symposium: Active TB drug safety monitoring and management: a transformative approach to limit treatment-related patient harm
Reporting adverse events (AEs) from real-life clinical practice contributes to evidence for decision making that impacts prescribing practices and improves treatment safety. In 2015, the World Health Organization launched the active drug safety monitoring management (aDSM) strategy. The strategy aims to promote the safe use of new TB medicines and novel regimens and develop a robust safety database to proactively protect public health.
Chair: Antonia Kwiecien (MSH, PHT)
• Improving TB patient safety and management: the Georgia experience
Nino Lomtadze, SIAPS Consultant, Georgia
Friday, October 28
10:30-12:00 | Session Room 4, ACC Liverpool
Symposium: Challenging Tuberculosis in Urban Settings and Big Cities in African, Euro-Asian and Latin American countries
The world’s total urban population reached an estimated 3.8 billion in 2013, and is projected to swell to nearly 6.3 billion by 2050. In 2015, the urban population represented over half of the global population compared to about a third in 1960. During the last two decades, TB incidence has increased in urban settings and big cities as a result of several social and demographic factors, including poor TB control efforts and the rise and concentration of high-risk groups.
Chair: Pedro Suarez (MSH, HPG, Arlington, USA)
• 10:45-11:00: Addressing the TB control issue in fragile states: urban DOTS experience in Kabul, Afghanistan
Mohammad Rashidi Challenge TB, MSH, Afghanistan
Saturday, October 29
10:30-12:00 | Session Room 4, ACC Liverpool
Symposium: TB elimination initiative in countries of Latin America Region
There is heterogeneity in the distribution of tuberculosis (TB) incidence rates among countries of the Americas, from over 200 cases to less than 10 cases per 100,000 population. A group of low-incidence countries in the Latin America (LA) Region was constituted in 2000, including Chile, Costa Rica, Cuba, Uruguay and Venezuela as observer. In 2010, the united States, Canada and Puerto Rico were invited to join. The group aims to adapt TB control measures to these contexts, exchange North-South and South-South experiences, and develop a TB elimination plan aligned with WHO’s framework for TB elimination in low-incidence countries.
- Learn more about MSH’s work in tuberculosis here
- Follow the conference on Twitter (@MSHHealthImpact, @MSHActs, and @TBExpertMSH) with #LungHealth and #unionconf.